From: Statistical analysis plan for the EuroHYP-1 trial: European multicentre, randomised, phase III clinical trial of the therapeutic hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke
Population
Intervention group
Outcomes
Death
mRS > 2
N (%)
Relative risk (RR) (95% CI)
P
RR (95% CI)
Intention-to-treat (ITT)
Group 0
Group 1
Per protocol (PP)